Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ACRV Acrivon Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.70 -0.0% | $15.37 -0.2% |
| StockIQ Score | 48D+ Moderate Risk: High | 35F Weak Risk: High |
| Technical | 19F | 13F |
| Fundamental | 46D+ | 35F |
| Growth | 59C | 50C- |
| Fair Value | 55C | 38F |
| News | 100A+ | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Acrivon Therapeutics (ACRV) outperforms Ascentage Pharma (AAPG) in nearly every category. Its investor score (62 vs. 37) and technical score (71 vs. 18) are significantly higher, showing stronger market confidence and technical strength. ACRV also has a moderate rating, while AAPG is rated weak. Only growth (59 vs. 50) and valuation (55 vs. 38) scores are closer, but ACRV still leads overall.